Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

1474 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 107
Pantethine Studied for Efficacy in Treating Pantothenate Kinase-Associated Neurodegeneration in Children

Pantethine Studied for Efficacy in Treating Pantothenate Kinase-Associated Neurodegeneration in Children

by Lauren Taylor from In The Cloud Copy Pantothenate kinase-associated neurodegeneration or PKAN is a rare, inherited condition in which the affected child experiences progressive degeneration in certain parts of…

Continue Reading Pantethine Studied for Efficacy in Treating Pantothenate Kinase-Associated Neurodegeneration in Children
Positive Proof-of-Concept Data Reported on GLPG1205 for IPF

Positive Proof-of-Concept Data Reported on GLPG1205 for IPF

Overall, Galapagos works to develop small-molecule treatments for patients with a variety of conditions. In a recent press release, the company reported positive top-line data from the Phase 2 PINTA…

Continue Reading Positive Proof-of-Concept Data Reported on GLPG1205 for IPF
Axcella Presents its Investigational Products to Treat Liver Diseases and Type 2 Diabetes

Axcella Presents its Investigational Products to Treat Liver Diseases and Type 2 Diabetes

Axcella is a biotechnology company that has developed a new system of treating complex diseases. Its lead candidates are products that treat two liver diseases, as well as NASH, which…

Continue Reading Axcella Presents its Investigational Products to Treat Liver Diseases and Type 2 Diabetes
A Possible Link Exists Between Endophthalmitis and COVID-19

A Possible Link Exists Between Endophthalmitis and COVID-19

For the entirety of 2020, our lives have been dominated by COVID-19, the novel coronavirus linked to 64.5 million cases and 1.49 million deaths across the globe. In the United…

Continue Reading A Possible Link Exists Between Endophthalmitis and COVID-19
DANYELZA Approved for the Treatment of Neuroblastoma

DANYELZA Approved for the Treatment of Neuroblastoma

The FDA has recently approved DANYELZA for the treatment of neuroblastoma in pediatric patients over the age of one and adult patients affected by refractory or relapsed neuroblastoma. This approval…

Continue Reading DANYELZA Approved for the Treatment of Neuroblastoma
VK2809 for NASH Significantly Reduces LDL Cholesterol, Liver Fat

VK2809 for NASH Significantly Reduces LDL Cholesterol, Liver Fat

In November 2020, Viking Therapeutics ("Viking") shared insight into their metabolic disease program. According to Greg Zante, the Senior VP (SVP) of Finance for Viking, the company's treatment VK2809, licensed…

Continue Reading VK2809 for NASH Significantly Reduces LDL Cholesterol, Liver Fat
Experimental Charcot-Marie-Tooth Disease Treatment Looks Promising

Experimental Charcot-Marie-Tooth Disease Treatment Looks Promising

This week Hallmark Movies and Mysteries premiered The Christmas Bow, which features Joy Perry, a woman with Charcot-Marie-Tooth disease, playing a woman with CMT. And while CMT has been known…

Continue Reading Experimental Charcot-Marie-Tooth Disease Treatment Looks Promising
PEDFIC 1 Data Shows Odevixibat Benefits for PFIC

PEDFIC 1 Data Shows Odevixibat Benefits for PFIC

During the Association for the Study of Liver Diseases (AASLD) Liver Meeting, which took place from November 13 to 16, biopharmaceutical company Albireo Pharma ("Albireo) announced data from the Phase…

Continue Reading PEDFIC 1 Data Shows Odevixibat Benefits for PFIC
  • Go to the previous page
  • 1
  • …
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 185
  • Go to the next page
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info